Patients with KEAP1 mutant LUAD are known to have poor responses to checkpoint blockade (19, 65), and our previous work has similarly demonstrated that this also holds true in our Keap1 mutant orthotopic tumor mouse model (50). This evidence concerns the gene KEAP1 and neoplasm.